Risk for heart failure events is decreased and health status is improved in patients with HFmrEF and HFpEF receiving finerenone.

A study has found that there is a dose-dependent relationship between increased risk for depression and cardiometabolic diseases.

The recent success of drug therapies such as semaglutide and tirzepatide has fueled obesity research. In a phase 2 trial that enrolled patients with type 2 diabetes (ClinicalTrials.gov Identifier: ...

Lifetime occurrence of sleep talking was significantly associated with increased stroke risk, while occurrence of sleep talking in the past year did not have a significant association.

Dual antiplatelet therapy with clopidogrel and aspirin can benefit patients with mild ischemic stroke when initiated up to 72 hours after symptom onset.

There is increased incidence of cardiovascular disease among patients who are immigrants that live in an area with low neighborhood-level income.

Stroke burden and the contribution of several risk factors have increased from 1990 to 2021 on the global, regional, and national level.

Late morning eating time was associated with a lower risk for cardiovascular disease mortality among individuals with type 2 diabetes.

In patients at high risk for AKI receiving cardiac surgery, delayed remote ischemic preconditioning reduces AKI risk. Delayed remote ischemic preconditioning reduces acute kidney injury (AKI) risk ...

In patients with NSTEMI, OHS was associated with higher mortality, cardiac arrest, AKI, renal replacement therapy, and respiratory failure requiring intubation. Obesity hypoventilation syndrome (OHS) ...

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) warranting optimized management.

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.